Close

We use cookies to improve your experience of our website. Privacy Policy

Skip to main content

Institute of Bioengineering

Search
Menu

Events

Progress in Tissue Regeneration and CNS Biomarkers with Professor Gorka Orive

Image: Professor Gorka Orive
Professor Gorka Orive

Date: 29 November 2018   Time: 12:30 - 13:30

Abstract
There are some drug delivery and regenerative medicine technologies that have seen several firsts in the last few years. In my conference I will summarize my experience in nano and microtechnologies including cell-laden hydrogels. In this approach, transplanted cells are protected from immune rejection by an artificial, semipermeable membrane, potentially allowing transplantation without the need for immunosuppression. Interestingly, the field of biological therapies constitutes a relatively new biotechnology that has been a breakthrough in the stimulation and acceleration of soft-tissue and bone healing. The efficiency of this process lies in the local and continuous delivery of a wide range of growth factors and proteins, mimicking the needs of the physiological wound healing and reparative tissue processes. This field has been extended to many different fields, including orthopedics, sports medicine, dentistry, cosmetic and periodontal medicine and cosmetic, plastic and maxillofacial surgery. I will end my talk describing my last entrepreneurship project, a company based on developing innovative technologies and tools and discovering new biomarkers for the diagnosis and early prediction of Alzheime's Disease as well as for exploring new therapeutic strategies for this and other CNS diseases.

Biography
Prof. Orive is Associate Professor in Pharmacy at the University of the Basque Country and founder of GEROA DIAGNOSTICS, a biotechnological company whose mission is to improve the health, the life-quality and medical care of patients suffering from Alzheimer’s disease (www.geroa.net). He is scientific advisor of the Laboratory of Regenerative Medicine at BTI Biotechnology Institute, a biotech and dental implant company from Vitoria (Spain).

He has over 243 scientific publications and participation in more than 500 international conferences. He has currently a H-index of 55 (one of the highest at his age) and close to 11,800 citations. His main interests include micro/nano encapsulation of drugs, cell therapy, biomaterials, prevention/treatment of CNS neurodegenerative diseases and regenerative medicine using scaffolds for bone regeneration and plasma rich in growth factors.

Location:  SEMS Seminar Room, 3rd floor Engineering Building, Mile End